BioCentury | Jul 28, 2020
Emerging Company Profile

Frazier, Marcadia founders reunite for rare endocrine diseases in MBX’s $34.6M A round

...September, included OrbiMed, New Enterprise Associates, Indiana Philanthropic Venture Fund, Indiana Seed Fund III and Twilight Venture Partners...
...$34.6 million Investors: Frazier Healthcare Partners, OrbiMed Advisors, NEA, IU PhV, Indiana Seed Fund III, Twilight Venture Partners...
BioCentury | Apr 14, 2014
Financial News

Assembly completes venture financing

...Type: Venture financing Raised: Not disclosed. Investors: Luson Bioventures; BioCrossroads; Johnson & Johnson Development Corp.; Twilight Venture Partners...
BioCentury | Mar 7, 2011
Strategy

Metabolic wellspring

...candidates. The price should suit Marcadia's investors, which included Frazier Healthcare Ventures; 5AM Ventures and Twilight Venture Partners...
BioCentury | May 16, 2007
Financial News

Marcadia raises $15 million

...series A round led by Frazier Healthcare Ventures and founding investor 5AM Ventures. Founding investor Twilight Venture Partners...
BioCentury | Apr 18, 2005
Company News

Ambrx board of directors update

...Ambrx Inc. , San Diego, Calif. Business: Chemistry, Endocrine Appointed: August Watanabe, a partner at Twilight Venture Partners...
BioCentury | Jan 10, 2005
Company News

Semafore management update

Semafore Pharmaceuticals Inc. , Indianapolis, Ind. Business: Cancer Hired: Ronald Henriksen as CEO and a director, while remaining chief investment officer at Twilight Ventures Partners WIR Staff...
BioCentury | Dec 6, 2004
Financial News

Endocyte raises $22.6 million

...series C-2 round led by Burrill. Other investors included Blue Chip Venture; Triathlon Venture Partners; Twilight Venture Partners...
Items per page:
1 - 7 of 7
BioCentury | Jul 28, 2020
Emerging Company Profile

Frazier, Marcadia founders reunite for rare endocrine diseases in MBX’s $34.6M A round

...September, included OrbiMed, New Enterprise Associates, Indiana Philanthropic Venture Fund, Indiana Seed Fund III and Twilight Venture Partners...
...$34.6 million Investors: Frazier Healthcare Partners, OrbiMed Advisors, NEA, IU PhV, Indiana Seed Fund III, Twilight Venture Partners...
BioCentury | Apr 14, 2014
Financial News

Assembly completes venture financing

...Type: Venture financing Raised: Not disclosed. Investors: Luson Bioventures; BioCrossroads; Johnson & Johnson Development Corp.; Twilight Venture Partners...
BioCentury | Mar 7, 2011
Strategy

Metabolic wellspring

...candidates. The price should suit Marcadia's investors, which included Frazier Healthcare Ventures; 5AM Ventures and Twilight Venture Partners...
BioCentury | May 16, 2007
Financial News

Marcadia raises $15 million

...series A round led by Frazier Healthcare Ventures and founding investor 5AM Ventures. Founding investor Twilight Venture Partners...
BioCentury | Apr 18, 2005
Company News

Ambrx board of directors update

...Ambrx Inc. , San Diego, Calif. Business: Chemistry, Endocrine Appointed: August Watanabe, a partner at Twilight Venture Partners...
BioCentury | Jan 10, 2005
Company News

Semafore management update

Semafore Pharmaceuticals Inc. , Indianapolis, Ind. Business: Cancer Hired: Ronald Henriksen as CEO and a director, while remaining chief investment officer at Twilight Ventures Partners WIR Staff...
BioCentury | Dec 6, 2004
Financial News

Endocyte raises $22.6 million

...series C-2 round led by Burrill. Other investors included Blue Chip Venture; Triathlon Venture Partners; Twilight Venture Partners...
Items per page:
1 - 7 of 7